APA (7th ed.) Citation

A, W., C, O., AS, D., X, B., MJ, N., M, S., . . . LH, M. (2024). Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer. Molecular cancer therapeutics, 23(6), 809. https://doi.org/10.1158/1535-7163.MCT-23-0550

Chicago Style (17th ed.) Citation

A, Wallace-Povirk, et al. "Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer." Molecular Cancer Therapeutics 23, no. 6 (2024): 809. https://doi.org/10.1158/1535-7163.MCT-23-0550.

MLA (9th ed.) Citation

A, Wallace-Povirk, et al. "Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer." Molecular Cancer Therapeutics, vol. 23, no. 6, 2024, p. 809, https://doi.org/10.1158/1535-7163.MCT-23-0550.